Unbound MEDLINE | Atrial fibrillation journal articles from PubMed

Download the Free Unbound MEDLINE PubMed App to your smartphone or tablet.

Available for iPhone, iPad, iPod touch, and Android.

Atrial fibrillation [keywords]

44826 results

Lee KM, Shukla V, Oxman AD, et al.
New oral anticoagulants versus warfarin for stroke prevention in atrial fibrillation: Development of coverage decision frameworks. [Journal Article]
Value Health 2013 May; 16(3):A296.

Barrett AM, Dibenedetti DB, Phatak H, et al.
Structured review of patient-reported outcome instruments for assessing patients with atrial fibrillation. [Journal Article]
Value Health 2013 May; 16(3):A293.

Mallow PJ, Hsiao CW, Rizzo JA
Cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy for the treatment of atrial fibrillation in canada. [Journal Article]
Value Health 2013 May; 16(3):A289.

Jegathisawaran J, Bowen JM, Khondoker F, et al.
Systematic review of cost-effectiveness analyses of dabigatran versus warfarin for atrial fibrillation across different health care systems. [Journal Article]
Value Health 2013 May; 16(3):A288.

Coleman CI, Baker WL, Limone BL
Cost-effectiveness of newer anticoagulants for stroke prevention in atrial fibrillation: A systematic literature review. [Journal Article]
Value Health 2013 May; 16(3):A287.

Rosado-Buzzo A, Garcia-Mollinedo L, Luna-Casas G, et al.
Economic evaluation of apixaban for atrial fibrillation in costa Rica. [Journal Article]
Value Health 2013 May; 16(3):A286.

Harrington AR, Armstrong EP, Nolan P, et al.
Lifetime costs and life-years gained associated with apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation. [Journal Article]
Value Health 2013 May; 16(3):A286.

Marmarali B, Ozdemir O, Bozkurt K, et al.
The cost-effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillation (AF) in Turkey. [Journal Article]
Value Health 2013 May; 16(3):A285.

Asukai Y, Maniadakis N, Carcedo D, et al.
Cost-effectiveness of rivaroxaban for the prevention of stroke in patients with non-valvular atrial fibrillation - a multinational study. [Journal Article]
Value Health 2013 May; 16(3):A285.

You J
Cost-effectiveness of new oral anticoagulants for patients with atrial fibrillation - a decision analysis. [Journal Article]
Value Health 2013 May; 16(3):A285-6.

Previous New Search Next